301033 迈普医学
2024/03 - 三个月2023/122022/122021/122020/12

盈利能力分析
净资产收益率 ROE (%)2.3346.6016.1109.84611.643
总资产报酬率 ROA (%)1.9105.3374.8127.4859.383
投入资产回报率 ROIC (%)2.1535.9445.2438.35610.780

边际利润分析
销售毛利率 (%)81.29282.00684.00682.38683.481
营业利润率 (%)32.73420.90721.17628.42532.031
息税前利润/营业总收入 (%)33.00621.03120.41633.99734.981
净利润/营业总收入 (%)26.12417.70618.30229.05529.841

收益指标分析
经营活动净收益/利润总额(%)75.68385.95364.80251.31760.182
价值变动净收益/利润总额(%)5.7927.68419.98213.71412.308
营业外收支净额/利润总额(%)-0.013-0.511-3.46515.2838.004

偿债能力分析
流动比率 (X)5.6103.9592.9147.6994.491
速动比率 (X)4.9703.5752.5547.3084.197
资产负债率 (%)17.15619.20219.10822.8870.242
带息债务/全部投入资本 (%)2.0892.50510.63214.06211.966
股东权益/带息债务 (%)4,414.3733,680.851826.510595.461725.819
股东权益/负债合计 (%)482.886420.789423.348334.818310.246
利息保障倍数 (X)119.43591.336-398.06876.614214.493

营运能力分析
应收账款周转天数 (天)25.29122.21614.50715.29217.550
存货周转天数 (天)237.752240.943291.585250.574286.410